Thoracic Oncology
-
Osimertinib plus chemo beat chemo alone in patients with advanced EGFR-mutated NSCLC who advanced on first-line osimertinib
Experts said the results of the COMPEL trial support continued treatment with osimertinib beyond progression in this patient population.
-
Study explores geographic disparities in tobacco dependence treatment among veterans with COPD
Study author Arianne K. Baldomero, MD, said that reducing geographic barriers will require multidisciplinary approaches and innovative, equitable health care solutions.
-
Case discussions to address complexities of mediastinal lymphadenopathy diagnosis
Sebastian Kurz, MD, PhD, FCCP, will chair a Wednesday afternoon panel session that will guide attendees through imaging findings, differential diagnoses, and clinical decision-making in mediastinal lymphadenopathy.
-
90th anniversary sessions to reflect on past, present, and future of field
Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.
-
Discussion to examine sublobar resection for early-stage lung cancer
Muhammad S. Ali, MD, MS, FCCP, will chair a Monday afternoon panel session on strategies for early-stage lung cancer in the age of sublobar resection.
-
Panelists to preview updated CHEST guidelines on pneumothorax, persistent air leak
Kamran Mahmood, MD, MPH, FCCP, will chair a Tuesday session that will offer a sneak peek at the clinical issues in CHEST guidelines scheduled to be released next year.
-
Revolutionizing respiratory care: Bedside ultrasound for diaphragm assessment
Diaphragm ultrasound is a safe, noninvasive tool that evaluates respiratory muscle function, aiding in diagnosis, weaning from ventilation, and management of lung disease.
-
Study identifies key environmental exposures associated with risk of interstitial lung disease
Bradford C. Bemiss, MD, MSc, said the findings underscore the importance of asking patients about potential workplace inhalation exposures.
-
New data confirms ILD as lung cancer risk factor
Bradford C. Bemiss, MD, and Claudia Henschke, PhD, MD, said the study clearly shows patients with interstitial lung disease have an increased risk of lung cancer.
-
Varenicline found effective for nicotine vaping cessation in youth
Researcher A. Eden Evins, MD, said she was surprised by the ineffectiveness of behavioral therapy alone.
-
EBUS nodal staging in early-stage non-small cell lung cancer
EBUS-TBNA disrupted the field of bronchoscopy by offering a minimally invasive, real-time imaging approach to biopsy, but recent data have emerged that show routine use of EBUS may warrant scrutiny.
-
Get informed and involved with smoking cessation strategies, advocacy
Sessions will equip attendees with the latest information about the health consequences of e-cigarettes and cannabis. Because the landscape has evolved so much recently, misconceptions are common—even among clinicians, said Evan Stepp, MD, FCCP.
